Test Code PUPYU Purines and Pyrimidines Panel, Random, Urine
Ordering Guidance
This is recommended screening test for the initial workup of a suspected disorder of purine and pyrimidine metabolism, particularly when clinical features are nonspecific, and includes measurement of purines, pyrimidines, uric acid, and S-sulfocysteine. If the clinical features are suggestive of molybdenum cofactor deficiency, isolated sulfite oxidase deficiency, and hereditary xanthinuria, order SSCTU / S-Sulfocysteine Panel, Urine.
If this test is ordered with SSCTU, then SSCTU will be canceled.
Necessary Information
Patient's age is required.
Specimen Required
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 3 mL
Collection Instructions: Collect a random urine specimen.
CMH COLLECTION: 5 mL in sterile cup
Specimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Frozen | 90 days |
Useful For
Evaluating patients with symptoms suspicious for disorders of purine and pyrimidine metabolism
Monitoring patients with disorders of purine and pyrimidine metabolism
Laboratory evaluation of primary and secondary hyperuricemias
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Day(s) Performed
Tuesday, Thursday
Report Available
3 to 7 daysReporting Name
Purines and Pyrimidines Panel, UReference Values
Age range |
0-3 years |
4-6 years |
7-12 years |
13-18 years |
>18 years |
Uracil |
≤50 |
≤30 |
≤25 |
≤20 |
≤20 |
Thymine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Adenine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Hypoxanthine |
≤65 |
≤30 |
≤30 |
≤30 |
≤30 |
Xanthine |
≤54 |
≤21 |
≤35 |
≤15 |
≤20 |
Orotic |
≤4 |
≤4 |
≤3 |
≤3 |
≤5 |
Dihydroorotic acid |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Uric Acid |
350-2500 |
200-2000 |
200-1400 |
150-700 |
70-700 |
Deoxythymidine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Deoxyuridine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Thymidine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Uridine |
≤10 |
≤3 |
≤3 |
≤3 |
≤3 |
Deoxyadenosine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Deoxyinosine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Deoxyguanosine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Adenosine |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Inosine |
≤6 |
≤3 |
≤3 |
≤3 |
≤3 |
Guanosine |
≤4 |
≤3 |
≤3 |
≤3 |
≤3 |
5-Aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR) |
≤3 |
≤3 |
≤3 |
≤3 |
≤3 |
Succinyladenosine |
≤16 |
≤3 |
≤3 |
≤3 |
≤3 |
S-Sulfocysteine |
≤11 |
≤5 |
≤5 |
≤5 |
≤5 |
Dihydrouracil |
≤15 |
≤6 |
≤6 |
≤6 |
≤6 |
Dihydrothymine |
≤11 |
≤3 |
≤3 |
≤3 |
≤3 |
N-Carbamoyl-B-alanine |
≤30 |
≤10 |
≤10 |
≤10 |
≤10 |
N-Carbamoyl-B-aminoisobutyric |
≤20 |
≤3 |
≤3 |
≤3 |
≤3 |
All results reported as mmol/mol creatinine
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
82542